Search results for "Elba"

showing 10 items of 25 documents

Real-life use of elbasvir/grazoprevir in adults and elderly patients: a prospective evaluation of comedications used in the PITER cohort.

2021

Background In patients treated for HCV infection, potential drug–drug interactions (DDIs) can occur among direct-acting antiviral drugs (DAAs) and comedications used. The real-life effectiveness and safety of elbasvir/grazoprevir (ELB/GZR) among co-medicated HCV patients was evaluated. Methods We prospectively evaluated consecutive patients from 15 clinical centres participating in PITER who were treated with ELB/GZR and had been followed for at least 12 weeks after treatment. Data were prospectively collected on the use of comedications (including discontinuation, dose modification and addition of drugs) and potential DDIs with DAAs. Results Of the 356 patients with at least 12-week post-t…

Male030312 virologycombination therapytreatment experienced patientsDrug Combinationchronic hepatitis C drug drug interactions virus genotype 1 treatment experienced patients pump inhibitor use combination therapy treatment naive liver fibrosisgrazoprevir elbasvir80 and overAge FactorPharmacology (medical)Drug InteractionsProspective StudiesChronicProspective cohort studyliver fibrosisAged 80 and over0303 health sciencesAge FactorsImidazolesMiddle AgedHepatitis CDrug CombinationsInfectious DiseasesTreatment OutcomeDrug InteractionGrazoprevirCohortdrug drug interactionsFemalepump inhibitor useHumanmedicine.drugmedicine.medical_specialtyElbasvirQuinoxalinetreatment naiveelbasvirAntiviral AgentsNO03 medical and health sciencesInternal medicineQuinoxalinesmedicinechronic hepatitis CElbasvir GrazoprevirHumansImidazoleAgedBenzofuransAntiviral AgentPharmacology...business.industrygrazoprevirCarbamazepineHepatitis C Chronicmedicine.diseaseComorbidityDiscontinuationBenzofuranAge Factors; Aged; Aged 80 and over; Antiviral Agents; Benzofurans; Drug Combinations; Drug Interactions; Female; Hepatitis C Chronic; Humans; Imidazoles; Male; Middle Aged; Prospective Studies; Quinoxalines; Treatment Outcomebusinessvirus genotype 1Antiviral therapy
researchProduct

NMDA receptor antagonist felbamate reduces behavioral deficits and blood-brain barrier permeability changes after experimental subarachnoid hemorrhag…

2007

Increased levels of glutamate and aspartate have been detected after subarachnoid hemorrhage (SAH) that correlate with neurological status. The NMDA receptor antagonist felbamate (FBM; 2-phenyl-1,3-propanediol dicarbamate) is an anti-epileptic drug that elicits neuroprotective effects in different experimental models of hypoxia-ischemia. The aim of this dose-response study was to evaluate the effect of FBM after experimental SAH in rats on (1) behavioral deficits (employing a battery of assessment tasks days 1-5 post-injury) and (2) blood-brain barrier (BBB) permeability changes (quantifying microvascular alterations according to the extravasation of protein-bound Evans Blue by a spectropho…

Malemedicine.medical_specialtyExcitotoxicityPhenylcarbamatesBehavioral deficitsmedicine.disease_causeCisterna magnaBlood–brain barrierNeuroprotectionReceptors N-Methyl-D-AspartateFelbamateRats Sprague-Dawleychemistry.chemical_compoundInternal medicinemedicineAnimalsAnimals; Blood-Brain Barrier; Rats; Subarachnoid Hemorrhage; Evans Blue; Behavioral deficits; Cognitive deficits; NMDA receptor; FelbamatePostural BalanceEvans BlueBehavior AnimalDose-Response Relationship Drugbusiness.industryCognitive deficitsMicrocirculationBody WeightGlutamate receptorSubarachnoid HemorrhageNMDA receptorFelbamateRatsEndocrinologymedicine.anatomical_structureNeuroprotective AgentsSpectrometry FluorescencechemistryBlood-Brain BarrierPropylene GlycolsAnesthesiaCerebrovascular CirculationNMDA receptorNeurology (clinical)businessmedicine.drugEvans BlueJournal of neurotrauma
researchProduct

Wielbarské vlivy v Čechách a na Moravě

2015

MarcomanniBohemia and MoraviafibulaebraceletsWielbark cultureamulet pendantsRoman period
researchProduct

La expansión geográfica de la renta del tabaco

2007

El monopolio real del tabaco fue decretado sólo para la Corona de Castilla en 1636. Debido a su reconocida eficacia, los gobernantes españoles intentaron implantarlo allá donde fuese políticamente posible. Después de la guerra de Sucesión, fue establecido en la Corona de Aragón, ya que estos territorios perdieron entonces su régimen foral de autonomía. Como las provincias vascas y Navarra consiguieron conservar su régimen foral, el Gobierno español no pudo someter allí el régimen general del estanco tabaquero y tuvo que contentarse con negociar soluciones que no perjudicasen al estanco general. Finalmente, en el contexto de las reformas borbónicas en América, la Renta del Tabaco fue gradual…

Monopolios fiscalesCataloniaBalearesAmérica virreal españolaTax monopoliesHumanidadesBasque CountrySardiniaHistoriaPaís VascoNavarraBalearic IslandsNavarreCataluñaTobaccoLongónSpanish Royal TreasuryUNESCO::HISTORIA::Historia moderna:Historia [Materias Investigacion]:HISTORIA::Historia moderna [UNESCO]Colonial Spanish AmericaReal HaciendaAragonAragónTabacoValenciaCerdeñaElba
researchProduct

The NMDA receptor complex: a promising target for novel antiepileptic strategies.

2001

Antiepileptic drugs (AEDs) cover a broad spectrum of pathological conditions ranging from seizures following congenital or acquired brain disorders to behavioural and psychiatric disorders and recently neuropathic pain. The need for novel antiepileptics raises from the expanding field of indications as well as from the fact, that special seizure types are refractory to common AEDs. In addition, many of the conventional antiepileptic drugs exhibit an unfavourable side-effect profile. Since there is growing evidence, that NMDA receptor activation might play a crucial role in epilepsy, NMDA receptor antagonists have become compounds of interest in preventing and treating seizures. This review …

N-Methylaspartatemedicine.medical_treatmentPharmacologyBiochemistryReceptors N-Methyl-D-AspartateFelbamatechemistry.chemical_compoundEpilepsyDrug DiscoveryIfenprodilmedicineAnimalsHumansRemacemidePharmacologyEpilepsybusiness.industryOrganic ChemistryMemantinemedicine.diseaseDizocilpineAnticonvulsantchemistryMolecular MedicineAnticonvulsantsbusinessEliprodilmedicine.drugCurrent medicinal chemistry
researchProduct

Two new species of oribatid mites of Lasiobelba (Acari, Oribatida, Oppiidae) from Nepal, including a key to all species of the genus

2014

Two new species of oribatid mites of the genus Lasiobelba (Oribatida, Oppiidae), Lasiobelba (Lasiobelba) daamsae sp. n. and Lasiobelba (Antennoppia) nepalica sp. n., are described from eastern Nepal. Lasiobelba (L.) daamsae sp. n. is most similar to L. (L.) remota Aoki, 1959 and L. (L.) gibbosa (Mahunka, 1985), however, it differs from both by the anterior part of pedotecta I specifically curved, rostrum pointed and exobothridial setae not shorter than bothridial setae. Lasiobelba (Antennoppia) nepalica sp. n. is most similar to L. (A.) granulata (Mahunka, 1986), however, it differs from the latter by the larger body size, exobothridial setae longer than rostral setae and bothridial setae n…

Oribatidanew speciesbiologyLasiobelbaRostrumIdentification keyZoologySetaBody sizeOribatid mitesbiology.organism_classificationkeyNepalGenusBotanylcsh:ZoologyKey (lock)AnimaliaAnimal Science and ZoologyAcarilcsh:QL1-991OribatidaOppiidaeEcology Evolution Behavior and SystematicsResearch Article
researchProduct

Neue Antiepileptika in der Entwicklung. Substanzen mit neuen Wirkmechanismen

2007

Unbestritten ist, dass sich durch den Einsatz von Antiepileptika der 2. Generation die Situation fur Epilepsiepatienten entscheidend verbessert hat. Dennoch bleibt ein Patientenklientel, bei dem keine ausreichende Anfallskontrolle erreicht wird, das therapierefraktar ist oder im Verlauf der Behandlung wird. Weiterentwicklungen von AEDs aus der 2. Generation (“follow-up compounds”) bzw. Wirkstoffe mit neuen Strukturen und Wirkmechanismen konnten zukunftig diese Lucke fullen.

PharmacologyValproic Acidbusiness.industrymedicinePharmaceutical SciencePiracetamPharmacology (medical)CarbamazepineLevetiracetamPharmacologybusinessmedicine.drugFelbamatePharmazie in unserer Zeit
researchProduct

Influence of carbenoxolone on the anticonvulsant efficacy of conventional antiepileptic drugs against audiogenic seizures in DBA/2 mice

2004

Carbenoxolone, the succinyl ester of glycyrrhetinic acid, is an inhibitor of 11beta-hydroxy steroid dehydrogenase and gap junctional intercellular communication. It is currently used in clinical treatment of ulcer diseases. Systemic administration of carbenoxolone (1-40 mg/kg, intraperitoneally (i.p.)) was able to produce a dose-dependent decrease in DBA/2 audiogenic seizure severity score. Glycyrrhizin, an analogue of carbenoxolone inactive at the gap-junction level, was unable to affect audiogenic seizures at doses up to 30 mg/kg. In combination with conventional antiepileptic drugs, carbenoxolone, 0.5 mg/kg, i.p., which per se did not significantly affect the occurrence of audiogenic sei…

PhenytoinAudiogenic seizureGap junctionmedicine.medical_treatmentCarbenoxoloneMotor ActivityLamotriginePharmacologyEpilepsy ReflexFelbamateMicemedicineAnimalsAnticonvulsant potencyPharmacologyValproateEpilepsybusiness.industryDrug SynergismCarbamazepineFelbamateCarbamazepineAnticonvulsantAcoustic StimulationMice Inbred DBAPhenytoinDBA/2CarbenoxoloneAnticonvulsantsPhenobarbitalbusinessDiazepamAntiepileptic drugmedicine.drug
researchProduct

Evaluating the impact of roughness in soil moisture and optical thickness retrievals over the VAS area

2014

International audience

Valencia Anchor Station[SDE.MCG]Environmental Sciences/Global ChangesL - MEB modelSoil scienceSurface finishELBARA - IIsoil roughnessEnvironmental sciencesoil moistureWater content[SPI.SIGNAL]Engineering Sciences [physics]/Signal and Image processingComputingMilieux_MISCELLANEOUSRemote sensingSMOS
researchProduct

Grazoprevir/elbasvir for the immediate treatment of recently acquired HCV genotype 1 or 4 infection in MSM.

2020

Abstract Background In Europe, increases in HCV infection have been observed over the last two decades in MSM, making them a key population for recently acquired HCV. Alternative combinations of direct-acting antiviral agents against early HCV infection need to be assessed. Patients and methods In this pilot trial, MSM with recently acquired genotype 1 or 4 HCV infection were prospectively included and received 8 weeks of oral grazoprevir 100 mg and elbasvir 50 mg in a fixed-dose combination administered once daily. The primary endpoint was sustained virological response evaluated 12 weeks after the end of treatment (EOT) (SVR12). Secondary endpoints were the virological characterization of…

hepatitis C virusCyclopropanesMaleadverse eventmen who have sex with menHepacivirusmedicine.disease_causeSexual and Gender Minoritiesblood HIV RNA0302 clinical medicine[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseasesfollow-upClinical endpointMedicinePharmacology (medical)infections030212 general & internal medicinehepatitis ceducation.field_of_studySulfonamideshepatitis c rnaImidazolesvirus diseasesHepatitis Cvirologyhepatitis C virus genotype 13. Good healthEuropeInfectious DiseasesGrazoprevirRNA Viral030211 gastroenterology & hepatologyDrug Therapy CombinationMicrobiology (medical)medicine.medical_specialtyElbasvirGenotypeHepatitis C virusPopulationelbasvirAntiviral Agentsreinfection03 medical and health sciencesInternal medicineQuinoxalinesHumansHomosexuality MaleAdverse effecteducationplasmasuicideBenzofuransPharmacologybusiness.industrySurrogate endpointHIVgrazoprevirHepatitis C Chronicmedicine.diseaseAmidessurrogate endpoints[SDV.SP.PHARMA]Life Sciences [q-bio]/Pharmaceutical sciences/PharmacologyQuality of LifeCarbamatesbusinessThe Journal of antimicrobial chemotherapy
researchProduct